NO20034003D0 - Fremgangsmåte for fremstilling av imidazol-forbindelser - Google Patents

Fremgangsmåte for fremstilling av imidazol-forbindelser

Info

Publication number: NO20034003D0
Authority: NO; Norway
Prior art keywords: preparation; imidazole compounds; imidazole; compounds
Prior art date: 2001-03-12

Application number

NO20034003A

Other languages

English (en)

Other versions

NO20034003L (no

NO324954B1 (no

Inventor

Walter Ferdinand Mari Filliers

Rudy Laurent Maria Broeckx

Stefan Marcel Herman Leurs

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-12

Filing date

2003-09-10

Publication date

2003-09-10

2003-09-10 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2003-09-10 Publication of NO20034003D0 publication Critical patent/NO20034003D0/no

2003-10-22 Publication of NO20034003L publication Critical patent/NO20034003L/no

2008-01-14 Publication of NO324954B1 publication Critical patent/NO324954B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Epoxy Resins (AREA)

NO20034003A 2001-03-12 2003-09-10 Fremgangsmate for fremstilling av 4-(3-klorfenyl)-6-[(4-klorfenyl)hydroksy(1-metyl-1H-imidazol-5-yl)metyl]-1-metyl-2(1H)-kinolinon og dets farmasoytisk akseptable salter. NO324954B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01200928		2001-03-12
PCT/EP2002/002459 WO2002072574A1 (en)	2001-03-12	2002-03-05	Process for the preparation of imidazole compounds

Publications (3)

Publication Number	Publication Date
NO20034003D0 true NO20034003D0 (no)	2003-09-10
NO20034003L NO20034003L (no)	2003-10-22
NO324954B1 NO324954B1 (no)	2008-01-14

Family

ID=8180004

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20034003A NO324954B1 (no)	2001-03-12	2003-09-10	Fremgangsmate for fremstilling av 4-(3-klorfenyl)-6-[(4-klorfenyl)hydroksy(1-metyl-1H-imidazol-5-yl)metyl]-1-metyl-2(1H)-kinolinon og dets farmasoytisk akseptable salter.

Country Status (31)

Country	Link
US (1)	US6844439B2 (no)
EP (1)	EP1373255B1 (no)
JP (1)	JP4257698B2 (no)
KR (1)	KR100849042B1 (no)
CN (1)	CN1246318C (no)
AR (1)	AR035944A1 (no)
AT (1)	ATE287882T1 (no)
AU (1)	AU2002253101B2 (no)
BR (1)	BRPI0208075B8 (no)
CA (1)	CA2438421C (no)
CZ (1)	CZ300622B6 (no)
DE (1)	DE60202755T2 (no)
DK (1)	DK1373255T3 (no)
EA (1)	EA006770B1 (no)
EE (1)	EE05247B1 (no)
ES (1)	ES2236505T3 (no)
HR (1)	HRP20030695B1 (no)
HU (1)	HU230282B1 (no)
IL (2)	IL157839A0 (no)
MX (1)	MXPA03008205A (no)
MY (1)	MY124838A (no)
NO (1)	NO324954B1 (no)
NZ (1)	NZ528620A (no)
PL (1)	PL208238B1 (no)
PT (1)	PT1373255E (no)
SI (1)	SI1373255T1 (no)
SK (1)	SK287807B6 (no)
TW (1)	TWI249532B (no)
UA (1)	UA74871C2 (no)
WO (1)	WO2002072574A1 (no)
ZA (1)	ZA200307117B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2291455T3 (es)	2001-03-12	2008-03-01	Avanir Pharmaceuticals	Compuestos de bencimidazol para modular ige e inhibir la proliferacion celular.
AU2003270426A1 (en)	2002-09-12	2004-04-30	Avanir Pharmaceuticals	PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
TWI276631B (en)	2002-09-12	2007-03-21	Avanir Pharmaceuticals	Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
CA2559221A1 (en) *	2004-03-18	2005-09-29	Brigham And Women's Hospital, Inc.	Methods for the treatment of synucleinopathies
ATE471316T1 (de) *	2004-05-03	2010-07-15	Janssen Pharmaceutica Nv	Diastereoselektives syntheseverfahren mit 6-brom- 4-(3-chlorphenyl)-2-methoxychinolin
CA2563807C (en) *	2004-05-03	2012-11-20	Janssen Pharmaceutica N.V.	Diastereoselective synthesis process for the preparation of imidazole compounds
CN100567290C (zh)	2004-05-03	2009-12-09	詹森药业有限公司	锂化n-甲基咪唑在亚磺基亚胺上的非对映选择性加成
JP2009521470A (ja)	2005-12-23	2009-06-04	リンクメディシンコーポレイション	シヌクレイン障害の治療
WO2009151683A2 (en) *	2008-03-12	2009-12-17	Link Medicine Corporation	Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
KR101044430B1 (ko) *	2009-09-25	2011-06-27	듀오백코리아 주식회사	요추받이를 포함하는 의자의 등 지지 장치
KR101107900B1 (ko) *	2009-10-21	2012-01-25	성용기업 주식회사	의자용 허리지지장치
PT3385395T (pt)	2015-08-17	2020-05-06	Kura Oncology Inc	Métodos de tratamento de doentes com cancro usando inibidores da farnesiltransferase
US11124839B2 (en)	2016-11-03	2021-09-21	Kura Oncology, Inc.	Methods of treating cancer patients with farnesyltransferase inhibitors
US10954210B2 (en)	2016-12-08	2021-03-23	Hangzhou Solipharma Co., Ltd.	Crystal form of tipifarnib and preparation method and pharmaceutical composition thereof
EA202092787A1 (ru) *	2018-05-18	2021-02-09	Кура Онколоджи, Инк.	Синтез типифарниба

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW349948B (en)	1995-10-31	1999-01-11	Janssen Pharmaceutica Nv	Farnesyl transferase inhibiting 2-quinolone derivatives
AU711142B2 (en) *	1995-12-08	1999-10-07	Janssen Pharmaceutica N.V.	Farnesyl protein transferase inhibiting (imidazol-5-YL)methyl-2-quinolinone derivatives
TW591030B (en) *	1997-03-10	2004-06-11	Janssen Pharmaceutica Nv	Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
ATE366250T1 (de)	1997-04-25	2007-07-15	Janssen Pharmaceutica Nv	Chinazolinone die farnesyltransferase hemmen
IL141239A0 (en) *	1998-08-27	2002-03-10	Pfizer Prod Inc	Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
DE69923849T2 (de)	1998-08-27	2006-01-12	Pfizer Products Inc., Groton	Quinolin-2-on-derivate verwendbar als antikrebsmittel

2002
- 2002-03-05 PL PL363263A patent/PL208238B1/pl unknown
- 2002-03-05 EE EEP200300442A patent/EE05247B1/xx unknown
- 2002-03-05 SI SI200230100T patent/SI1373255T1/xx unknown
- 2002-03-05 CN CNB02806335XA patent/CN1246318C/zh not_active Expired - Lifetime
- 2002-03-05 CZ CZ20032704A patent/CZ300622B6/cs not_active IP Right Cessation
- 2002-03-05 EA EA200300998A patent/EA006770B1/ru not_active IP Right Cessation
- 2002-03-05 BR BR0208075-3 patent/BRPI0208075B8/pt not_active IP Right Cessation
- 2002-03-05 KR KR1020037010091A patent/KR100849042B1/ko not_active Expired - Lifetime
- 2002-03-05 EP EP02722184A patent/EP1373255B1/en not_active Expired - Lifetime
- 2002-03-05 PT PT02722184T patent/PT1373255E/pt unknown
- 2002-03-05 MX MXPA03008205A patent/MXPA03008205A/es active IP Right Grant
- 2002-03-05 ES ES02722184T patent/ES2236505T3/es not_active Expired - Lifetime
- 2002-03-05 HU HU0303443A patent/HU230282B1/hu unknown
- 2002-03-05 US US10/471,215 patent/US6844439B2/en not_active Expired - Lifetime
- 2002-03-05 CA CA2438421A patent/CA2438421C/en not_active Expired - Lifetime
- 2002-03-05 HR HR20030695A patent/HRP20030695B1/xx not_active IP Right Cessation
- 2002-03-05 IL IL15783902A patent/IL157839A0/xx unknown
- 2002-03-05 SK SK1246-2003A patent/SK287807B6/sk unknown
- 2002-03-05 DK DK02722184T patent/DK1373255T3/da active
- 2002-03-05 DE DE60202755T patent/DE60202755T2/de not_active Expired - Lifetime
- 2002-03-05 WO PCT/EP2002/002459 patent/WO2002072574A1/en not_active Ceased
- 2002-03-05 NZ NZ528620A patent/NZ528620A/en not_active IP Right Cessation
- 2002-03-05 AT AT02722184T patent/ATE287882T1/de active
- 2002-03-05 JP JP2002571490A patent/JP4257698B2/ja not_active Expired - Lifetime
- 2002-03-05 AU AU2002253101A patent/AU2002253101B2/en not_active Expired
- 2002-03-11 MY MYPI20020866A patent/MY124838A/en unknown
- 2002-03-11 TW TW091104444A patent/TWI249532B/zh not_active IP Right Cessation
- 2002-03-11 AR ARP020100873A patent/AR035944A1/es active IP Right Grant
- 2002-05-03 UA UA2003087776A patent/UA74871C2/uk unknown
2003
- 2003-09-10 IL IL157839A patent/IL157839A/en unknown
- 2003-09-10 NO NO20034003A patent/NO324954B1/no not_active IP Right Cessation
- 2003-09-11 ZA ZA200307117A patent/ZA200307117B/en unknown

Also Published As

Publication number	Publication date
US20040138256A1 (en)	2004-07-15
DE60202755T2 (de)	2006-03-30
DE60202755D1 (de)	2005-03-03
ZA200307117B (en)	2004-09-13
HRP20030695B1 (hr)	2011-07-31
CA2438421A1 (en)	2002-09-19
PL363263A1 (en)	2004-11-15
AU2002253101B2 (en)	2007-08-09
EA006770B1 (ru)	2006-04-28
HU230282B1 (hu)	2015-12-28
HK1063315A1 (zh)	2004-12-24
SK12462003A3 (sk)	2004-06-08
EP1373255B1 (en)	2005-01-26
EA200300998A1 (ru)	2004-02-26
HUP0303443A3 (en)	2012-09-28
ES2236505T3 (es)	2005-07-16
SK287807B6 (sk)	2011-10-04
US6844439B2 (en)	2005-01-18
IL157839A0 (en)	2004-03-28
JP2004523575A (ja)	2004-08-05
KR100849042B1 (ko)	2008-07-29
SI1373255T1 (no)	2005-08-31
UA74871C2 (en)	2006-02-15
CZ20032704A3 (en)	2004-03-17
NO20034003L (no)	2003-10-22
KR20030079971A (ko)	2003-10-10
AR035944A1 (es)	2004-07-28
PL208238B1 (pl)	2011-04-29
ATE287882T1 (de)	2005-02-15
BRPI0208075B1 (pt)	2018-02-14
BRPI0208075B8 (pt)	2021-05-25
MXPA03008205A (es)	2004-01-29
CN1496363A (zh)	2004-05-12
CZ300622B6 (cs)	2009-07-01
BR0208075A (pt)	2004-03-02
TWI249532B (en)	2006-02-21
EE200300442A (et)	2003-12-15
NO324954B1 (no)	2008-01-14
JP4257698B2 (ja)	2009-04-22
CA2438421C (en)	2010-05-18
CN1246318C (zh)	2006-03-22
WO2002072574A1 (en)	2002-09-19
NZ528620A (en)	2005-01-28
IL157839A (en)	2008-07-08
HRP20030695A2 (en)	2005-02-28
EE05247B1 (et)	2009-12-15
DK1373255T3 (da)	2005-05-23
MY124838A (en)	2006-07-31
EP1373255A1 (en)	2004-01-02
PT1373255E (pt)	2005-05-31
HUP0303443A2 (hu)	2004-01-28

Publication	Publication Date	Title
NO20042680L (no)	2004-06-25	Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20030012L (no)	2003-03-03	Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20040027L (no)	2004-01-05	Fremgangsmate for fremstillingen av escitalopram
NO20030163L (no)	2003-02-27	Fremgangsmate for fremstilling av olefiner
NO20043586L (no)	2004-10-07	Fremgangsmate for fremstilling av organiske forbindelser
NO20040278L (no)	2004-01-21	Fremgangsmate for fremstilling av perindopril
NO20034003D0 (no)	2003-09-10	Fremgangsmåte for fremstilling av imidazol-forbindelser
NO20033433D0 (no)	2003-08-01	Fremgangsmåte for fremstilling av 2-(2-pyridylmetyl)sulfinyl- 1H-benzimidasol
NO20032731D0 (no)	2003-06-16	Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner
NO20044814L (no)	2004-01-07	Fremgangsmate for fremstilling av combretastaniner
NO20035538D0 (no)	2003-12-11	Fremgangsmåte for fremstilling av zaleplon
NO20042640L (no)	2004-06-23	Fremgangsmate for fremstilling av ekinocandinderivater
NO20023445L (no)	2003-01-20	Fremgangsmåte for fremstilling av peptider
NO20030515D0 (no)	2003-02-03	Fremgangsmåte for fremstilling av dinapsolin
NO20035586D0 (no)	2003-12-15	Fremgangsmåte for fremstilling av cykloheksanol-derivater
FR2826002B1 (fr)	2004-12-03	Procede de preparation de composes bromodifluoroacetiques
NO20035136D0 (no)	2003-11-18	Fremgangsmåte til fremstilling av imipenem
NO20025465D0 (no)	2002-11-14	FremgangsmÕte for fremstilling av bifenylforbindelser
NO20033147L (no)	2003-09-02	Fremgangsmåte for fremstilling av rent ondansetronhydrogenklorid-dihydrat
NO20024887L (no)	2002-10-10	FremgangsmÕte for fremstilling av benzokondenserte heterosykliske forbindelser
NO20023702L (no)	2002-08-06	Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20035138D0 (no)	2003-11-18	Fremgangsmåte til fremstilling av amorft natriumsilastatin
NO20052396D0 (no)	2005-05-13	Fremgangsmate for fremstilling av spirolactonforbindelser
NO20020328D0 (no)	2002-01-22	Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20041193L (no)	2004-03-22	Fremgangsmåte til fremstilling av beta-ionylidenacetaldehyd

Legal Events

Date	Code	Title	Description
2022-04-11	MK1K	Patent expired